PDSB PDS Biotechnology Corp

Price (delayed)

$0.8239

Market cap

$46.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.64

Enterprise value

$44.88M

?
Relative Growth: Rel. Growth: 9
Relative Strength: Rel. Strength: 46
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 5

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product candidate, EG-1962, a polymer-based microparticle used for the treatment ...

Highlights
PDS Biotechnology's debt has shrunk by 76% YoY and by 72% QoQ
PDS Biotechnology's EPS has increased by 30% YoY and by 4.5% QoQ
The equity has plunged by 192% from the previous quarter and by 122% YoY
The quick ratio has plunged by 84% YoY and by 79% from the previous quarter

Key stats

What are the main financial stats of PDSB

PDSB stock price

How has the PDS Biotechnology stock price performed over time
Intraday
-9.46%
1 week
-16.83%
1 month
277.07%
1 year
-21.53%
YTD
7.03%
QTD
-6.49%

Financial performance

How have PDS Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$27.83M
Net income
-$33.67M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 19% YoY and by 3.9% from the previous quarter
PDS Biotechnology's net income has increased by 8% YoY

Price vs fundamentals

How does PDSB's price correlate with its fundamentals

Growth

What is PDS Biotechnology's growth rate over time

Valuation

What is PDS Biotechnology stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
PDS Biotechnology's EPS has increased by 30% YoY and by 4.5% QoQ
The equity has plunged by 192% from the previous quarter and by 122% YoY

Efficiency

How efficient is PDS Biotechnology business performance
PDSB's ROE has shrunk by 105% QoQ
The ROA has shrunk by 73% YoY and by 33% QoQ
PDS Biotechnology's ROIC has plunged by 65% from the previous quarter and by 17% YoY

Dividends

What is PDSB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PDSB.

Financial health

How did PDS Biotechnology financials performed over time
PDS Biotechnology's total assets is 29% less than its total liabilities
The quick ratio has plunged by 84% YoY and by 79% from the previous quarter
PDSB's current ratio has dropped by 80% year-on-year and by 75% since the previous quarter
The equity has plunged by 192% from the previous quarter and by 122% YoY
The debt to equity has dropped by 130% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.